Latest Public health genomics Stories
OMAHA, Neb., and CHARLOTTESVILLE, Va., Sept. 16 /PRNewswire-FirstCall/ -- Transgenomic (BULLETIN BOARD: TBIO) today announced a partnership with Key Genomics to develop a molecular diagnostic test which will guide clinicians in their choice of currently available treatments for ovarian cancer.
SCOTTSDALE, Ariz., Sept. 8 /PRNewswire/ -- Two Scottsdale businesses Saturday (September 13) inaugurate what they believe to be the first public wellness workshop series to allow people to explore the intersection between personal genomics and individual health.
By Chen, Lei-Shih Kwok, Oi-Man; Goodson, Patricia Objectives. We examined US health educators' likelihood of adopting genomic competencies-specific skills and knowledge in public health genomics-into health promotion and the factors influencing such likelihood. Methods.
Private Access, Inc, and Genetic Alliance, a 501(c)(3) organization, announced today that they have formed a novel public-private partnership designed to simultaneously protect patients' privacy rights while creating a faster and more cost effective way for researchers to connect with patients in order to find causes and treatments for chronic illnesses and diseases.
A scientific collaboration aimed at advancing pharmacogenomics research through the development of novel methodologies and advanced reagents for targeted medical resequencing was announced today by Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, and the Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre, a provider of pharmacogenomics research, content, and services.
Congress passed a landmark anti-genetic discrimination bill on Thursday that forbids insurance companies from setting premiums or determining enrollment eligibility for people whose genetic information shows a predisposition to certain illnesses.
Many public health officials, doctors and medical ethicists worry about the proliferation of these tests, which are without any significant government oversight, even though many of them are being sold as tools for making important medical decisions.
Although advances in genomic medicine for common adult chronic diseases such as heart disease, diabetes, and cancer hold promise for improved prevention, diagnosis and treatment, health professionals and the public are not prepared to effectively integrate these new tools into practice, according to a study released today by researchers from the Department of Veterans Affairs and the RAND Corporation.
Scientists have found clusters of new gene variants that raise the risk of Type 2 diabetes - and how the researchers did it is as important as what they found.